Clinical Characteristics of Asymptomatic Thromboembolism in Psychiatric Inpatients: A Retrospective Study
Yimeng Geng,Peifen Zhang,Yanmeng Pan,Huaizhi Wang,Yi Chen,Jianbo Lai,Shaohua Hu
DOI: https://doi.org/10.2147/ndt.s438835
IF: 2.989
2024-03-08
Neuropsychiatric Disease and Treatment
Abstract:Yimeng Geng, 1, &ast Peifen Zhang, 1, &ast Yanmeng Pan, 1, &ast Huaizhi Wang, 2 Yi Chen, 1 Jianbo Lai, 1, 3, 4 Shaohua Hu 1– 4 1 Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China; 2 Department of Psychiatry, Wenzhou Medical University, Wenzhou, 325035, People's Republic of China; 3 The Key Laboratory of Mental Disorder's Management in Zhejiang Province, Hangzhou, 310003, People's Republic of China; 4 Brain Research Institute of Zhejiang University, Hangzhou, 310003, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shaohua Hu, Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, The Key Laboratory of Mental Disorder's Management, Brain Research Institute of Zhejiang University, Hangzhou, 310003, People's Republic of China, Email Purpose: Venous thromboembolism (VTE) poses a significant threat to individuals' health, yet its correlation with mental disorders remains underappreciated. Here, we conducted a retrospective analysis to explore the characteristics of psychiatric patients presenting with VTE. Methods: We retrospectively analyzed psychiatric inpatients with elevated plasma D-dimer levels at the Mental Health Center, First Affiliated Hospital, Zhejiang University School of Medicine, from January 2014 to January 2022. The inclusion criteria comprised comprehensive demographic and clinical profiles, including laboratory and imaging findings. Results: A cohort of 33 eligible patients was included, with plasma D-dimer levels ranging from 880 to 10,700 μg/L FEU. Significantly higher D-dimer levels were observed in patients diagnosed with severe mental disorders (SMD), such as schizophrenia and bipolar disorder, compared to those with mild mental disorders (MMD), including depression and anxiety disorders (p = 0.007). Furthermore, individuals receiving antipsychotic medications for less than one year exhibited elevated D-dimer levels compared to those on treatment for over one year (p = 0.005). However, normalization of D-dimer levels did not demonstrate a significant association with psychiatric diagnosis or treatment duration (p > 0.05). Conclusion: Our findings suggest that patients diagnosed with SMD or those undergoing antipsychotic treatment for less than one year may have elevated D-dimer levels, indicating a potential predisposition to VTE severity. This underscores the importance of recognizing VTE risk in individuals with severe mental disorders and warrants further investigation into the impact of antipsychotic treatment duration on thrombotic risk. Keywords: asymptomatic thromboembolism, D-dimer, psychiatric disorder, risk factors Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), stands as the third most prevalent cardiovascular disorder, with an overall incidence ranging from 1 to 2 per thousand inhabitants. 1,2 VTE is acknowledged as a multifactorial disorder, and associated risk factors, such as psychosocial elements, have garnered increased attention. 3,4 Recent findings highlight VTE as a significant contributor to sudden death among inpatients with psychiatric disorders. 5 Estimates from the global burden of disease position psychiatric disorders among the top 20 causes of disability. 6 Previous investigations have shown that individuals with psychiatric disorders typically experience a reduced life expectancy, on average, by at least 10 years compared to the general population, primarily due to an elevated risk of cardiovascular disease. 7–9 Notably, approximately 4% of unanticipated sudden deaths among psychiatric patients are linked to PE, with VTE incidence peaking at 11.6% within a three-month timeframe in this population. 10,11 Moreover, reports suggest an exponential increase in VTE incidence with advancing age, particularly among patients older than 40 years. 12 However, diagnosing VTE among psychiatric patients presents significant challenges, potentially attributed to factors such as the sedative effects of medications, immobilization, or psychopathological symptoms. Furthermore, symptomatic VTE occurrences could lead to fatal outcomes. Consequently, early screening for asymptomatic VTE, identification of potential triggering factors, and implementation of effective diagnostic measures among psychiatric patients are imperative. In this study, we undertook a retrospective investigation targeting asymptomatic venous -Abstract Truncated-
psychiatry,clinical neurology